We license various intellectual properties (patents and/or know-how) to our partners.
As for the innovative licenses which we expect can be commercialized,
we propose the originality and effectiveness of the license-related researches
through our workshop activities, etc.
In our licensing business, we mainly receive the fee based on a contract
and the fixed royalty from the sales on The R&D-based-commercialized
products.
| Therapeutic products using BDNF for periodontal disease We have been developing these products with DENTSPLY international Inc (U.S.A.). We have gained the fixed research fund for 5 years, and already signed up an agreement for the royalty after commercializing and selling. Researches have reported that BDNF promote the parodontium regeneration. Now we are researching a new treatment for periodontal disease. The new treatment is to mix BDNF with carriers and replant them@into destroyed parodontium. Periodontal disease is reportedly a common disease that 80% people over 30 years old suffer from. This disease deteriorates your parodontium such as periodontal ligaments and alveolar bones. |

